Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 5:13 PM
Ignite Modification Date: 2025-12-24 @ 5:13 PM
NCT ID: NCT06312150
Eligibility Criteria: Inclusion Criteria (principal study): * Diagnoses, received after the year 2015 (Wilms' tumour, Ewing's Sarcoma, Osteosarcoma, Soft tissue sarcomas, Carcinomas, Neuroblastoma) * Informed consent signed by parents or the patient if over 18 years of age * Planned follow-up for 5 years * Availability of a sufficient peripheral blood sample for analysis at onset. * Age between 0 and 20 years Inclusion Criteria (substudy): * Diagnosis of Ewing's Sarcoma, Neuroblastoma, Paediatric leukaemia, Tumours of the breast, lung, colon and ovary * Informed consent signed by parents or by the patient if 18 years of age19 * Planned follow-up for 5 years * Availability of biological samples (peripheral blood, bone marrow blood, biopsy at onset) sufficient for the study investigations. * Age between 0 and 20 years for paediatric patients referred to CROP Centres - Florence and Pisa * Age between 19 and 75 years for adult patients attending the San Donato Hospital in Arezzo Inclusion criteria (control group) * Age between 0 and 30 years * No evidence of acute or chronic infectious/inflammatory disease Exclusion Criteria (for every partecipants to the principal study and substudy): * Patients with HIV, HCV and HBV seropositivity (HBSAg) due to biohazard and bias related to patients' immunological status that could influence gene expression and tumour behaviour. * Pregnant or lactating patients as the altered hormonal panel is a factor disturbing the expression of β3ARs
Healthy Volunteers: True
Sex: ALL
Minimum Age: 1 Day
Maximum Age: 75 Years
Study: NCT06312150
Study Brief:
Protocol Section: NCT06312150